Exercise before surgery: could ReHIIT boost recovery for bowel cancer patients?
NCT ID NCT07313332
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study will test a combined exercise program called ReHIIT (resistance training plus high-intensity interval cycling) in 14 healthy adults. The goal is to see how the body responds to this type of exercise, so researchers can later compare it to colorectal cancer patients. The study does not involve any drugs or treatments for cancer itself.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ReHIIT training (resistance exercise plus high-intensity interval cycling)
What this could lead to
If successful, this could help design better exercise programs to prepare colorectal cancer patients for surgery and improve recovery.
What could go wrong
This is a very small pilot study in healthy volunteers, not cancer patients. Results may not translate to actual patients or lead to any treatment changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERVENTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical School, University of Nottingham, Royal Derby Hospital
Derby, Derbyshire, DE223DT, United Kingdom